Ganglioside patterns in amyotrophic lateral sclerosis brain regions
- PMID: 4037752
- DOI: 10.1002/ana.410180111
Ganglioside patterns in amyotrophic lateral sclerosis brain regions
Abstract
In a search for evidence of biochemical disorders in regions of postmortem brain other than the motor cortex in amyotrophic lateral sclerosis (ALS), ganglioside patterns were also examined in the frontal, temporal, and parahippocampal gyrus cortex. In 21 ALS brains studied (20 sporadic, 1 familial), abnormal patterns were found in the frontal cortex (81%), temporal cortex (75%), motor cortex (70%), and parahippocampal gyrus cortex (71%). Patterns were established by measuring the percentage distribution of 12 ganglioside species. Two abnormal patterns were detected. One was based on low proportions of GD1b, GT1b, and GQ1b associated with high proportions of GM2 and GD3 (GM1, GD1a, GD2, and GT1a values were normal). The second abnormality was the appearance of Gx. Neither abnormality was seen in the 13 non-ALS control brains. The first, and predominant, abnormality was found in the frontal cortex in 14 brains, and the second was observed in 13 brains; 10 brains showed both abnormalities. These findings thus constitute evidence that the disease process in ALS extends beyond the motor cortex and involves neurons in several brain areas.
Similar articles
-
Implications of altered brain ganglioside profiles in amyotrophic lateral sclerosis (ALS).Acta Neurobiol Exp (Wars). 1990;50(4-5):505-13. Acta Neurobiol Exp (Wars). 1990. PMID: 2130665 Review.
-
Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.BMC Genomics. 2007 Jan 23;8:26. doi: 10.1186/1471-2164-8-26. BMC Genomics. 2007. PMID: 17244347 Free PMC article.
-
Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex.Amyotroph Lateral Scler. 2006 Dec;7(4):201-10. doi: 10.1080/17482960600947689. Amyotroph Lateral Scler. 2006. PMID: 17127558
-
Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.Ann Neurol. 1989 Jan;25(1):98-102. doi: 10.1002/ana.410250118. Ann Neurol. 1989. PMID: 2913936
-
[An autopsied case of dominantly affecting upper motor neuron with atrophy of the frontal and temporal lobes--with special reference to primary lateral sclerosis].Rinsho Shinkeigaku. 1995 Apr;35(4):384-90. Rinsho Shinkeigaku. 1995. PMID: 7614764 Review. Japanese.
Cited by
-
The presence and clinical significance of autoantibodies in amyotrophic lateral sclerosis: a narrative review.Neurol Sci. 2024 Sep;45(9):4133-4149. doi: 10.1007/s10072-024-07581-x. Epub 2024 May 11. Neurol Sci. 2024. PMID: 38733435 Review.
-
Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine.Transl Neurodegener. 2022 Nov 7;11(1):48. doi: 10.1186/s40035-022-00322-0. Transl Neurodegener. 2022. PMID: 36345044 Free PMC article. Review.
-
Exploring Sphingolipid Implications in Neurodegeneration.Front Neurol. 2020 May 21;11:437. doi: 10.3389/fneur.2020.00437. eCollection 2020. Front Neurol. 2020. PMID: 32528400 Free PMC article. Review.
-
A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.J Neurol Neurosurg Psychiatry. 1993 Apr;56(4):361-4. doi: 10.1136/jnnp.56.4.361. J Neurol Neurosurg Psychiatry. 1993. PMID: 7683329 Free PMC article.
-
Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration.PLoS One. 2011;6(12):e29285. doi: 10.1371/journal.pone.0029285. Epub 2011 Dec 15. PLoS One. 2011. PMID: 22195039 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous